Publication
Published papers
HOXB5 confers tamoxifen resistance in breast cancer cells and promotes tumor aggression and progression.
Kim CY, Kim YC, Oh JH†, and Kim MH†.
NR4A1 regulates tamoxifen resistance by suppressing ERK signaling in ER-positive breast cancer.
Kim YC, Kim CY, Oh JH†, and Kim MH†.
HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer
Kim CY, Kim YC, Oh JH†, and Kim MH†.
Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer.
Oh JH, Lee J-Y, Kim KH, Kim CY, Jeong DS, Cho Y, Nam KT†, and Kim MH†.
The LncRNA HOTAIRM1 promotes tamoxifen resistance by mediating HOXA1 expression in ER+ breast cancer cells.
Kim CY, Oh JH, Lee J-Y†, and Kim MH†.
RAE1 mediated ZEB1 expression promotes epithelial-mesenchymal transition in breast cancer
Oh JH, Lee J-Y, Yu S, Cho Y, Hur S, Nam KT†, and Kim MH†.